Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic β-cells

被引:140
作者
Gehrmann, W. [1 ]
Elsner, M. [1 ]
Lenzen, S. [1 ]
机构
[1] Hannover Med Sch, Inst Clin Biochem, D-30623 Hannover, Germany
关键词
beta-oxidation; G-protein-coupled receptors; insulin secretion; mitochondria; non-esterified fatty acids; peroxisomes; reactive oxygen species; type 2 diabetes mellitus; PROTEIN-COUPLED RECEPTOR; CHAIN FATTY-ACIDS; DEPENDENT INSULIN-SECRETION; ENZYME GENE-EXPRESSION; ACYL-COA OXIDASE; ELECTRON-TRANSPORT; SUPEROXIDE-PRODUCTION; CELLULAR PRODUCTION; NAD(P)H OXIDASE; CYTOCHROME-C;
D O I
10.1111/j.1463-1326.2010.01265.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronically elevated concentrations of non-esterified fatty acids (NEFAs) in type 2 diabetes may be involved in beta-cell dysfunction and apoptosis. It has been shown that long-chain saturated NEFAs exhibit a strong cytotoxic effect upon insulin-producing cells, while short-chain as well as unsaturated NEFAs are well tolerated. Moreover, long-chain unsaturated NEFAs counteract the toxicity of palmitic acid. Reactive oxygen species (ROS) formation and gene expression analyses together with viability assays in different beta-cell lines showed that the G-protein-coupled receptors 40 and 120 do not mediate lipotoxicity. This is independent from the role, which these receptors, specifically GPR40, play in the potentiation of glucose-induced insulin secretion by saturated and unsaturated long-chain NEFAs. Long-chain NEFAs are not only metabolized in the mitochondria but also in peroxisomes. In contrast to mitochondrial beta-oxidation, the acyl-coenzyme A (CoA) oxidases in the peroxisomes form hydrogen peroxide and not reducing equivalents. As beta-cells almost completely lack catalase, they are exceptionally vulnerable to hydrogen peroxide generated in peroxisomes. ROS generation in the respiratory chain is less important because overexpression of catalase and superoxide dismutase in the mitochondria do not provide protection. Thus, peroxisomally generated hydrogen peroxide is the likely ROS that causes pancreatic beta-cell dysfunction and ultimately beta-cell death.
引用
收藏
页码:149 / 158
页数:10
相关论文
共 76 条
[1]   Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].
Boden, G .
DIABETES, 1997, 46 (01) :3-10
[2]   CELLULAR PRODUCTION OF HYDROGEN-PEROXIDE [J].
BOVERIS, A ;
CHANCE, B ;
OSHINO, N .
BIOCHEMICAL JOURNAL, 1972, 128 (03) :617-&
[3]   The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids [J].
Briscoe, CP ;
Tadayyon, M ;
Andrews, JL ;
Benson, WG ;
Chambers, JK ;
Eilert, MM ;
Ellis, C ;
Elshourbagy, NA ;
Goetz, AS ;
Minnick, DT ;
Murdock, PR ;
Sauls, HR ;
Shabon, U ;
Spinage, LD ;
Strum, JC ;
Szekeres, PG ;
Tan, KB ;
Way, JM ;
Ignar, DM ;
Wilson, S ;
Muir, AI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) :11303-11311
[4]   A family of fatty acid binding receptors [J].
Brown, AJ ;
Jupe, S ;
Briscoe, CP .
DNA AND CELL BIOLOGY, 2005, 24 (01) :54-61
[5]   β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes [J].
Butler, AE ;
Janson, J ;
Bonner-Weir, S ;
Ritzel, R ;
Rizza, RA ;
Butler, PC .
DIABETES, 2003, 52 (01) :102-110
[6]   Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation [J].
Carpentier, A ;
Mittelman, SD ;
Lamarche, B ;
Bergman, RN ;
Giacca, A ;
Lewis, GF .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 276 (06) :E1055-E1066
[7]   The role of long-chain fatty acyl-CoA esters in β-cell signal transduction [J].
Corkey, BE ;
Deeney, JT ;
Yaney, GC ;
Tornheim, K ;
Prentki, M .
JOURNAL OF NUTRITION, 2000, 130 (02) :299S-304S
[8]  
Dansen TB, 2001, IUBMB LIFE, V51, P223
[9]   THE TRIUMVIRATE - BETA-CELL, MUSCLE, LIVER - A COLLUSION RESPONSIBLE FOR NIDDM [J].
DEFRONZO, RA .
DIABETES, 1988, 37 (06) :667-687
[10]   Structural requirements for the cytoprotective actions of mono-unsaturated fatty acids in the pancreatic β-cell line, BRIN-BD11 [J].
Dhayal, S. ;
Welters, H. J. ;
Morgan, N. G. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (08) :1718-1727